PUBLISHER: QYResearch | PRODUCT CODE: 1874336
PUBLISHER: QYResearch | PRODUCT CODE: 1874336
The global market for EVA Infusion Bags was estimated to be worth US$ 292 million in 2024 and is forecast to a readjusted size of US$ 437 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on EVA Infusion Bags cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
EVA Infusion Bags are sterile, single-use medical devices that are used for the preparation, preservation and administration of parenteral solutions. They are usually made from PVC-free, DEHP-free and latex-free EVA material. In order to enable transferring additional ingredients (such as lipids) into a separate container to extend the beyond-use date (BUD) of the sterile solution, EVA Infusion Bags often come up with the form of single-chamber or multi-chambers.
Global key players of EVA Infusion Bags include Baxter International, B. Braun, Fresenius Kabi, Weigao Group, ICU Medical, etc. The top five players hold a share about 64%.
North America is the dominate consumption region of EVA Infusion Bags, accounting for about 40% of the total revenue, followed by APAC, with the consumption market share of 32%. EVA Infusion bag in the Asia-Pacific region once again grew substantially in 2024, due predominantly to an aging population, growing prosperity and the associated increase in health awareness. China is the most populous country in the world, with a rapidly growing percentage of elderly people. In order to manage this demographic challenge, the country's health care system has been undergoing expansion and renovation for years.
In terms of product type, Multi-Chambers is the largest segment, occupied for a share of 51%. In terms of application, Hospital is the largest application, occupied for a share of 61%.
The growing demand for advanced drug delivery systems in healthcare. EVA infusion bags offer several advantages over traditional PVC (Polyvinyl Chloride) bags, including lower risk of leaching harmful chemicals, greater flexibility, and compatibility with a wider range of drugs. As healthcare providers and pharmaceutical companies prioritize patient safety and drug efficacy, the adoption of EVA infusion bags is increasing. Moreover, regulatory trends favoring the use of safer and more compatible materials in medical devices also contribute to the market growth of EVA infusion bags.
This report aims to provide a comprehensive presentation of the global market for EVA Infusion Bags, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of EVA Infusion Bags by region & country, by Type, and by Application.
The EVA Infusion Bags market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EVA Infusion Bags.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of EVA Infusion Bags manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of EVA Infusion Bags in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of EVA Infusion Bags in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.